<DOC>
	<DOCNO>NCT00050492</DOCNO>
	<brief_summary>This study look biological marker primary retinal vasculitis useful understanding cause disease . It evaluate progression , develop monitor treatment . Biological marker substance ( e.g. , chemical call cytokine chemokines antibody ) associate disease condition retinal vasculitis . Retinal vasculitis inflammation blood vessel retina cause retinal damage subsequent loss vision . It occur ( primary retinal vasculitis ) , part systemic vascular disease . The study evaluate patient primary retinal vasculitis compare finding two group patient retinal vasculitis patient Behcet 's syndrome HIV-infected patient undergo HAART therapy . Patients 10 year age sight-threatening retinal vasculitis may eligible study . ( page 6 protocol , # 4 Study Design Methods , say age range 2 year old ; page 10 , # 5 Participant Inclusion Exclusion Criteria , say initial enrollment include patient age 10 year ) . Upon enter study , participant 10 teaspoon blood withdrawn arm vein needle 6 month 12 month later . The blood sample analyze cytokine , chemokines adhesion molecule , certain type antibody , infectious agent .</brief_summary>
	<brief_title>Biological Markers Retinal Vasculitis</brief_title>
	<detailed_description>Retinal vasculitis major component ocular inflammation play critical role retinal tissue damage subsequent vision loss . Retinal vasculitis occur primary ocular disease secondarily , component systemic vascular disease . Unfortunately , little known primary retinal vasculitis . The initiating event retinal vasculitis likely multifactorial . Nevertheless , underlie pathologic mechanism drive process may common . We hypothesize biological marker retinal vasculitis , , cytokine , chemokines , adhesion molecule , T-cell surface marker autoantibody useful determine disease progression , understand mechanisms pathogenesis , identify therapeutic strategy monitor treatment . The purpose objective study investigate select biological marker collect clinical biologic information well understand natural history condition indicative primary retinal vasculitis . The goal study evaluate patient primary retinal vasculitis disorder . We compare group patient two additional type uveitis patient retinal vasculitis ; patient Behcet 's syndrome HIV patient undergo HAART therapy immune recovery uveitis . Patient evaluation consist follow procedure : full ocular examination , fluorescent angiogram study , blood collection therapy . Patient blood sample study evaluate presence three type biological marker ( 1 ) cytokine , chemokines adhesion molecule , ( 2 ) autoantibody ( 3 ) infectious agent . The primary outcome study identification biological marker patient retinal vasculitis .</detailed_description>
	<mesh_term>Vasculitis</mesh_term>
	<mesh_term>Retinal Vasculitis</mesh_term>
	<criteria>INCLUSION CRITERIA : Initial enrollment would include patient age 10 year sight threaten retinal vasculitis . Patients identified progressive disease stable disease . EXCLUSION CRITERIA : Patients age 10 pregnant exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 19, 2006</verification_date>
	<keyword>Ocular</keyword>
	<keyword>Cytokine</keyword>
	<keyword>Chemokine</keyword>
	<keyword>Viruses</keyword>
	<keyword>Autoantibody</keyword>
	<keyword>Retina</keyword>
	<keyword>Vasculitis</keyword>
	<keyword>Adhesion Molecules</keyword>
</DOC>